-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Tradegate System der Deutsche Börse AG (60%)EURSymbol FAD2-
ADVAXIS INCBörse Börse StuttgartEURSymbol FAD2
-
ADVAXIS INCBörse Börse DüsseldorfEURSymbol FAD2
-
ADVAXIS INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol FAD2
-
ADVAXIS INCBörse Börse MünchenEURSymbol FAD2
-
ADVAXIS INCBörse Quotrix System der Börse DüsseldorfEURSymbol FAD2
-
ISIN US0076243072 WKN: A2PGJ3USDSymbol ADXS
-
USDISIN US0076243072
-
EURSymbol FAD2
-
EURSymbol FAD2
-
Symbol FAD2
Währung
EUR
Börse
Tradegate System der Deutsche Börse AG (60%) Zeitzone: Europe/Berlin
Firmenname
Advaxis, Inc
Marktkapitalisierung
77.884.136 (+- 24%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
96.768.272 oder 59.000.000
Mitarbeiter
16 (+- 10%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
17 oder 14 Mitarbeiter
EBITDA -26.629.000
Buchwert 0.324
Dir gefallen die Informationen zu Advaxis?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Advaxis?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Advaxis?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Advaxis?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
38 News & Informationen zur Advaxis Aktie
$ADXS: New investors will love the forecast for Advaxis, Inc. : StockMarket
1.8m members in the StockMarket community. Welcome to /r/StockMarket! Our objective is to provide short and mid term trade ideas, market analysis & …
Advaxis Reports 3rd Quarter Ended July 31, 2021 Financial Results and Provides a Business Update
Entered definitive merger agreement with Biosight Ltd. to advance pipeline of clinical-stage oncology programs for solid tumors and hematological malignancies Initiated Phase 1 clinical trial… | September 10, 2021
Advaxis Reports 3rd Quarter Ended July 31, 2021 Financial Results and Provides a Business Update
Entered definitive merger agreement with Biosight Ltd. to advance pipeline of clinical-stage oncology programs for solid tumors and hematological…
53 Biggest Movers From Friday
Gainers Innate Pharma S.A. (NASDAQ:IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perfo…
35 Stocks Moving In Friday's Mid-Day Session
Gainers Cellect Biotechnology Ltd. (NASDAQ:APOP) shares jumped 35% to $7.43. Cellect Biotechnology announced the first ApoGraft transplantation …
Pre-market Movers: APOP, FBRX, ANY, AGIL, ADXS…
(RTTNews) – The following are some of the stocks making big moves in Friday's pre-market trading (as of 6.30 A.M. EDT). In the Green Cellect Bio…
3 Penny Stocks That Top Investors Are Watching Right Now
Why top investors are watching these penny stocks right now
Trending Penny Stocks to Buy in September? Check These 3 Out
Are these penny stocks on your September small-caps watchlist?
63 Biggest Movers From Yesterday
Gainers Support.com, Inc. (NASDAQ:SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume. TSR, Inc. (NASDAQ:TSRI) s…
45 Stocks Moving In Thursday's Mid-Day Session
Gainers Blue Water Acquisition Corp. (NASDAQ:BLUW) shares climbed 57% to $16.41. Blue Water Acquisition is expected to hold a special meeting of…
Advaxis, Inc., a Delaware corporation, or Advaxis, and Biosight Ltd., a company organized under the laws of the State of Israel, or Biosight, entered into an Agreement and Plan of Merger and Reorganiz
1.7m members in the StockMarket community. Welcome to /r/StockMarket! Our objective is to provide short and mid term trade ideas, market analysis & …
Global Cancer Vaccines Research Report 2021-2026: Leading Players are Merck & Co., GlaxoSmithKline and Dendreon
/PRNewswire/ — The
SHAREHOLDER ALERT: WeissLaw LLP Reminds ICON, ADXS, QADA; QADB, and SNR Shareholders About Its Ongoing Investigations
NEW YORK, July 20, 2021 /PRNewswire/ —
If you own shares in any of the companies… | July 20, 2021
Popular Penny Stocks to Buy in 2021? Here’s 4 You Should Know About
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates UFS, HBMD, ICBK, ADXS; Shareholders are Encouraged to Contact the Firm
NEW YORK, July 18, 2021 — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Domtar Corporation concerning potential violations of…
Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Advaxis, Inc. – ADXS
NEW YORK, July 16, 2021 /PRNewswire/– Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS… | July 17, 2021
Advaxis Announces Initiation of Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer
Study in biochemically recurrent prostate cancer expands off-the-shelf ADXS-HOT program to second indication…
Advaxis to Present at the Non-Small Cell Lung Cancer Drug Development Summit
PRINCETON, N.J., July 14, 2021 (GLOBE NEWSWIRE) — Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and…
SHAREHOLDER ALERT: WeissLaw LLP Reminds UFS, ADXS, QADA; QADB, and SNR Shareholders About Its Ongoing Investigations
NEW YORK, July 13, 2021 /PRNewswire/ —
If you own shares in any of the companies… | July 13, 2021
ADXS Stock Forecast 2021: Advaxis, Inc. Remains Hot with 536.4% Upside : StockMarket
1.7m members in the StockMarket community. Welcome to /r/StockMarket! Our objective is to provide short and mid term trade ideas, market analysis & …
7 Top Penny Stocks to Watch That You Probably Haven’t Heard Of
Lifshitz Law Firm, P.C. Announces Investigation of ADXS, KIN, MMAC, and GRA
NEW YORK, July 10, 2021 — Advaxis, Inc. Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of ADXS with Biosight…
Insights On The Neoantigens Global Market To 2028 – By Treatment, Therapeutic Specialty And Geography
DUBLIN, July 8, 2021 /PRNewswire/ — The “Neoantigens Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Treatment and Therapeutic Specialty”
Insights on the Neoantigens Global Market to 2028 – by Treatment, Therapeutic Specialty and Geography
/PRNewswire/ — The “Neoantigens Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Treatment and Therapeutic Specialty” report has been added to…
SeaSpine Lauded by Analysts After Spine Module Cleared by FDA
The Food and Drug Administration’s cleared SeaSpine's 7D Percutaneous Spine Module for spinal surgery. The company's shares are higher.
Advaxis, Inc. (NASDAQ: ADXS) Will Be Biosight Therapeutics With A Cash Position Of $50 Million : StockMarket
1.7m members in the StockMarket community. Welcome to /r/StockMarket! Our objective is to provide short and mid term trade ideas, market analysis & …
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Advaxis, Inc. Merger
WILMINGTON, Del., July 07, 2021 — Rigrodsky Law, P.A. announces that it is investigating Advaxis, Inc. regarding possible breaches of fiduciary duties and other violations of law related…
ADVAXIS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of ADXS and Encourages Investors to Contact the Firm
NEW YORK, July 07, 2021 — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Advaxis, Inc….
Biohaven Leaps After Posting $93M Sales for Migraine Drug
Biohaven's Nurtec was approved for migraine treatment in February 2020 and for prevention this past May. Q2 sales: $93 million.
INVESTIGATION ALERT: Halper Sadeh LLP Investigates USCR, QTS, MCF, ADXS; Shareholders are Encouraged to Contact the Firm
NEW YORK, July 7, 2021 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
… | July 7, 2021
Mid-Afternoon Market Update: Dow Tumbles 300 Points; Advaxis Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 0.86% to 34,488.53 while the NASDAQ fell 0.08% to 14,626.98. The S&P also fell, dropping 0.48% to …
Top Biotech Penny Stocks to Buy This Week? 9 To Watch
Advaxis Jumps on Deal to Be Bought by Biosight
Advaxis shares advanced after the company agreed to be purchased by peer biotech Biosight of Israel.
Advaxis (ADXS) Stock Is Climbing On Merger News
ADXS stock is screaming for the top after the company announced that it has entered into a definitive merger agreement.
Advaxis and Biosight Announce Entry into Definitive Merger Agreement
– Combined Company Will Operate as Biosight Therapeutics to Advance Pipeline of Clinical-Stage Oncology Programs with Lead Program Aspacytarabine (BST-236)…
Hedge Funds Aren’t Crazy About U.S. Well Services, Inc. (USWS) Anymore
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter,…
Cancer Vaccines Market to reach US $10,688.8 Million By 2028 – Global Insights on Key Trends, COVID-19 Impact Analysis, Growth Drivers, Expansion Plans and Future Outlook: Adroit Market Research
Dallas, Texas, Jan. 15, 2021 (GLOBE NEWSWIRE) — The “Global Cancer Vaccines Market Size 2020, By Type (Preventive Cancer Vaccines, Therapeutic Cancer …